Evidence map›Paper›PMID 34200928›Full record

ReviewPharmaceutics2021

Factors Affecting Posterior Capsule Opacification in the Development of Intraocular Lens Materials.

Grace Cooksley, Joseph Lacey, Marcus K Dymond, Susan Sandeman

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Anterior Capsular Contraction Syndrome in Cataract Surgery: A Review of Challenges and Solutions.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  6. Article
  7. Article
  8. Posterior capsular opacification and YAG laser capsulotomy in uveitis patients following cataract surgery.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Application of Silicone in Ophthalmology: A Review.Materials (Basel, Switzerland) · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Grace CooksleySchool of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK.ORCID 0000-0001-8186-9442
Joseph LaceyThe Ridley Innovation Centre, Rayner Intraocular Lenses Limited, Worthing BN14 8AG, UK.
Marcus K DymondSchool of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK.ORCID 0000-0002-9903-4993
Susan SandemanSchool of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK.ORCID 0000-0001-8367-2758
University of Brighton · GB

Funding

University of Brighton Scholarship with the Doctoral Training Alliance Bioscience Programme G2059
6 · The paper itself

Abstract

Posterior capsule opacification (PCO) is the most common complication arising from the corrective surgery used to treat cataract patients. PCO arises when lens epithelial cells (LEC) residing in the capsular bag post-surgery undergo hyper-proliferation and transdifferentiation into myofibroblasts, migrating from the posterior capsule over the visual axis of the newly implanted intraocular lens (IOL). The developmental pathways underlying PCO are yet to be fully understood and the current literature is contradictory regarding the impact of the recognised risk factors of PCO. The aim of this review is firstly to collate the known biochemical pathways that lead to PCO development, providing an up-to-date chronological overview from surgery to established PCO formation. Secondly, the risk factors of PCO are evaluated, focussing on the impact of IOLs' properties. Finally, the latest experimental model designs used in PCO research are discussed to demonstrate the ongoing development of clinical PCO models, the efficacy of newly developed IOL technology, and potential therapeutic interventions. This review will contribute to current PCO literature by presenting an updated overview of the known developmental pathways of PCO, an evaluation of the impact of the risk factors underlying its development, and the latest experimental models used to investigate PCO. Furthermore, the review should provide developmental routes for research into the investigation of potential therapeutic interventions and improvements in IOL design in the aid of preventing PCO for new and existing patients.

Indexed as

clinical studiesexperimental modelsintraocular lenseslens epithelial cellspathophysiologyposterior capsule opacificationwound healing

Identifiers

PMID34200928
PMCPMC8230425
OpenAlexW3172850289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.